Overdosering kan medføre væskeophobninger og hyperviskositet, især hos patienter i risikogruppen, herunder ældre patienter eller patienter med nedsat nyrefunktion.
Overdose may lead to fluid overload and hyperviscosity, particularly in patients at risk, including elderly patients or patients with renal impairment.